Skip to main content
Top
Published in: Abdominal Radiology 4/2017

01-04-2017

Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors

Authors: Carolina Parada Villavicencio, Robert J. Mc Carthy, Frank H. Miller

Published in: Abdominal Radiology | Issue 4/2017

Login to get access

Abstract

Objective

To assess the diagnostic performance of the apparent diffusion coefficient (ADC) in predicting the Fuhrman nuclear grading of clear cell renal cell carcinomas (ccRCC).

Materials and methods

A total of 129 patients who underwent partial and radical nephrectomies with pathology-proven ccRCC were retrospectively evaluated. Histopathological characteristics and nuclear grades were analyzed. In addition, conventional magnetic resonance imaging (MRI) features were assessed in consensus by two radiologists to discriminate nuclear grading. ADC values were obtained from a region of interest (ROI) measurement in the ADC maps calculated from diffusion-weighted imaging (DWI) using b values of 50, 500, and 800 s/mm2. The threshold values for predicting and differentiating low-grade cancers (Fuhrman I–II) from high grade (Fuhrman III–IV) was obtained using binary logistic regression. The ADC cut-off value for differentiating low- and high-grade tumors was determined using classification analysis.

Results

Significant associations (P < 0.001) were found between nuclear grading, conventional MR features, and DWI. Hemorrhage, necrosis, perirenal fat invasion, enhancement homogeneity, and cystic component were identified as independent predictors of tumor grade. High-grade ccRCC had significantly lower mean ADC values compared to low-grade tumors. An ADC cut-off value of 1.6 × 10−3 mm2/s had an optimal predictive percentage of 65.5% for low-grade tumors above this threshold and 81% for high-grade ccRCC below this threshold. Overall predictive accuracy was 70.5%.

Conclusion

The addition of ADC values to a model based on MRI conventional features demonstrates increased sensitivity and high specificity improving the distinguishing accuracy between both high-grade and low-grade ccRCC.
Literature
1.
go back to reference Kleihues P, Sobin L (2004) Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: World Health Organization Classification of Tumours International Agency for Research on Cancer (IARC), pp 9–11 Kleihues P, Sobin L (2004) Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: World Health Organization Classification of Tumours International Agency for Research on Cancer (IARC), pp 9–11
2.
go back to reference Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F (2015) International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 67:519–530CrossRefPubMed Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F (2015) International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 67:519–530CrossRefPubMed
3.
go back to reference Delahunt B, Cheville JC, Martignoni G, et al. (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490–1504CrossRefPubMed Delahunt B, Cheville JC, Martignoni G, et al. (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490–1504CrossRefPubMed
4.
go back to reference Lohse CM, Blute ML, Zincke H, Weaver AL, Cheville JC (2002) Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118:877–886CrossRefPubMed Lohse CM, Blute ML, Zincke H, Weaver AL, Cheville JC (2002) Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118:877–886CrossRefPubMed
5.
go back to reference Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed
6.
go back to reference Delahunt B (2009) Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 22(Suppl 2):S24–S36CrossRefPubMed Delahunt B (2009) Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 22(Suppl 2):S24–S36CrossRefPubMed
7.
go back to reference Chen J, Ding J, Wu C, et al. (2013) Preoperatively evaluating the correlation between pathological grades and blood oxygenation level-dependent MRI in clear cell renal cell carcinomas. Acad Radiol 20:224–230CrossRefPubMed Chen J, Ding J, Wu C, et al. (2013) Preoperatively evaluating the correlation between pathological grades and blood oxygenation level-dependent MRI in clear cell renal cell carcinomas. Acad Radiol 20:224–230CrossRefPubMed
8.
go back to reference Bhatt JR, Finelli A (2014) Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol 11:517–525CrossRefPubMed Bhatt JR, Finelli A (2014) Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol 11:517–525CrossRefPubMed
9.
go back to reference Gandaglia G, Ravi P, Abdollah F, et al. (2014) Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 8:247–252CrossRefPubMedPubMedCentral Gandaglia G, Ravi P, Abdollah F, et al. (2014) Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 8:247–252CrossRefPubMedPubMedCentral
10.
go back to reference Sun M, Thuret R, Abdollah F, et al. (2011) Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 59:135–141CrossRefPubMed Sun M, Thuret R, Abdollah F, et al. (2011) Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 59:135–141CrossRefPubMed
11.
go back to reference Volpe A, Panzarella T, Rendon RA, et al. (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745CrossRefPubMed Volpe A, Panzarella T, Rendon RA, et al. (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745CrossRefPubMed
12.
go back to reference Cornelis F, Tricaud E, Lasserre AS, et al. (2015) Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol 25:24–31CrossRefPubMed Cornelis F, Tricaud E, Lasserre AS, et al. (2015) Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol 25:24–31CrossRefPubMed
13.
go back to reference Squillaci E, Manenti G, Cova M, et al. (2004) Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 24:4175–4179PubMed Squillaci E, Manenti G, Cova M, et al. (2004) Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 24:4175–4179PubMed
14.
go back to reference Kierans AS, Rusinek H, Lee A, et al. (2014) Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma. AJR Am J Roentgenol 203:W637–W644CrossRefPubMed Kierans AS, Rusinek H, Lee A, et al. (2014) Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma. AJR Am J Roentgenol 203:W637–W644CrossRefPubMed
15.
go back to reference Doganay S, Kocakoc E, Cicekci M, et al. (2011) Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions. Clin Radiol 66:420–425CrossRefPubMed Doganay S, Kocakoc E, Cicekci M, et al. (2011) Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions. Clin Radiol 66:420–425CrossRefPubMed
16.
go back to reference Dodelzon K, Mussi TC, Babb JS, Taneja SS, Rosenkrantz AB (2012) Prediction of growth rate of solid renal masses: utility of MR imaging features—preliminary experience. Radiology 262:884–893CrossRefPubMed Dodelzon K, Mussi TC, Babb JS, Taneja SS, Rosenkrantz AB (2012) Prediction of growth rate of solid renal masses: utility of MR imaging features—preliminary experience. Radiology 262:884–893CrossRefPubMed
17.
go back to reference Taouli B, Thakur RK, Mannelli L, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251:398–407CrossRefPubMed Taouli B, Thakur RK, Mannelli L, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251:398–407CrossRefPubMed
18.
go back to reference Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445CrossRefPubMed Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445CrossRefPubMed
19.
go back to reference Kang SK, Zhang A, Pandharipande PV, et al. (2015) DWI for renal mass characterization: systematic review and meta-analysis of diagnostic test performance. AJR Am J Roentgenol 205:317–324CrossRefPubMed Kang SK, Zhang A, Pandharipande PV, et al. (2015) DWI for renal mass characterization: systematic review and meta-analysis of diagnostic test performance. AJR Am J Roentgenol 205:317–324CrossRefPubMed
20.
go back to reference Goyal A, Sharma R, Bhalla AS, et al. (2012) Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 53:349–358CrossRefPubMed Goyal A, Sharma R, Bhalla AS, et al. (2012) Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 53:349–358CrossRefPubMed
21.
go back to reference Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195:W344–W351CrossRefPubMed Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195:W344–W351CrossRefPubMed
22.
go back to reference Divine G, Norton HJ, Hunt R, Dienemann J (2013) Statistical grand rounds: a review of analysis and sample size calculation considerations for Wilcoxon tests. Anesth Analg 117:699–710CrossRefPubMed Divine G, Norton HJ, Hunt R, Dienemann J (2013) Statistical grand rounds: a review of analysis and sample size calculation considerations for Wilcoxon tests. Anesth Analg 117:699–710CrossRefPubMed
23.
go back to reference Dexter F (2013) Wilcoxon-Mann-Whitney test used for data that are not normally distributed. Anesth Analg 117:537–538CrossRefPubMed Dexter F (2013) Wilcoxon-Mann-Whitney test used for data that are not normally distributed. Anesth Analg 117:537–538CrossRefPubMed
24.
go back to reference Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef
25.
go back to reference Xie Y, Ma X, Gu L, et al. (2016) Prognostic and clinicopathological significance of survivin expression in renal cell carcinoma: a systematic review and meta-analysis. Sci Rep 6:29794CrossRefPubMedPubMedCentral Xie Y, Ma X, Gu L, et al. (2016) Prognostic and clinicopathological significance of survivin expression in renal cell carcinoma: a systematic review and meta-analysis. Sci Rep 6:29794CrossRefPubMedPubMedCentral
26.
go back to reference Taouli B, Beer AJ, Chenevert T, et al. (2016) Diffusion-weighted imaging outside the brain: consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging 44:521–540CrossRefPubMedPubMedCentral Taouli B, Beer AJ, Chenevert T, et al. (2016) Diffusion-weighted imaging outside the brain: consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging 44:521–540CrossRefPubMedPubMedCentral
27.
go back to reference Baliyan V, Das CJ, Sharma S, Gupta AK (2014) Diffusion-weighted imaging in urinary tract lesions. Clin Radiol 69:773–782CrossRefPubMed Baliyan V, Das CJ, Sharma S, Gupta AK (2014) Diffusion-weighted imaging in urinary tract lesions. Clin Radiol 69:773–782CrossRefPubMed
28.
go back to reference Wang Y, Chen ZE, Nikolaidis P, et al. (2011) Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging 33:136–142CrossRefPubMed Wang Y, Chen ZE, Nikolaidis P, et al. (2011) Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging 33:136–142CrossRefPubMed
30.
go back to reference Koh DM, Lee JM, Bittencourt LK, Blackledge M, Collins DJ (2016) Body diffusion-weighted MR imaging in oncology: imaging at 3 T. Magn Reson Imaging Clin N Am 24:31–44CrossRefPubMed Koh DM, Lee JM, Bittencourt LK, Blackledge M, Collins DJ (2016) Body diffusion-weighted MR imaging in oncology: imaging at 3 T. Magn Reson Imaging Clin N Am 24:31–44CrossRefPubMed
31.
go back to reference Pedrosa I, Chou MT, Ngo L, et al. (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375CrossRefPubMed Pedrosa I, Chou MT, Ngo L, et al. (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375CrossRefPubMed
32.
go back to reference Vargas HA, Delaney HG, Delappe EM, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed Vargas HA, Delaney HG, Delappe EM, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed
34.
go back to reference Hammond NA, Lostumbo A, Adam SZ, et al. (2015) Imaging of adrenal and renal hemorrhage. Abdom Imaging 40:2747–2760CrossRefPubMed Hammond NA, Lostumbo A, Adam SZ, et al. (2015) Imaging of adrenal and renal hemorrhage. Abdom Imaging 40:2747–2760CrossRefPubMed
35.
go back to reference Zhang YD, Wu CJ, Wang Q, et al. (2015) Comparison of utility of histogram apparent diffusion coefficient and R2* for differentiation of low-grade from high-grade clear cell renal cell carcinoma. AJR Am J Roentgenol 205:W193–W201CrossRefPubMed Zhang YD, Wu CJ, Wang Q, et al. (2015) Comparison of utility of histogram apparent diffusion coefficient and R2* for differentiation of low-grade from high-grade clear cell renal cell carcinoma. AJR Am J Roentgenol 205:W193–W201CrossRefPubMed
36.
go back to reference Bai X, Wu CL (2012) Renal cell carcinoma and mimics: pathologic primer for radiologists. AJR Am J Roentgenol 198:1289–1293CrossRefPubMed Bai X, Wu CL (2012) Renal cell carcinoma and mimics: pathologic primer for radiologists. AJR Am J Roentgenol 198:1289–1293CrossRefPubMed
37.
go back to reference Beddy P, Genega EM, Ngo L, et al. (2014) Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 12:55–62CrossRefPubMed Beddy P, Genega EM, Ngo L, et al. (2014) Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 12:55–62CrossRefPubMed
38.
go back to reference Pichler M, Hutterer GC, Chromecki TF, et al. (2012) Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 137:283–289CrossRefPubMed Pichler M, Hutterer GC, Chromecki TF, et al. (2012) Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 137:283–289CrossRefPubMed
39.
go back to reference Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRefPubMed Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRefPubMed
40.
go back to reference Renshaw AA, Cheville JC (2015) Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma. Pathology 47:34–37CrossRefPubMed Renshaw AA, Cheville JC (2015) Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma. Pathology 47:34–37CrossRefPubMed
41.
42.
Metadata
Title
Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors
Authors
Carolina Parada Villavicencio
Robert J. Mc Carthy
Frank H. Miller
Publication date
01-04-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0981-7

Other articles of this Issue 4/2017

Abdominal Radiology 4/2017 Go to the issue